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Abstract
Excessive stimulation of the TLR4 axis through LPS reduces the expression of some cytokine genes in immune cells,
while stimulating the expression of immune defense genes during a subsequent bacterial infection. This endotoxin
tolerance (ET) is mediated via epigenetic mechanisms. Priming the udder of cows with LPS was shown to induce ET
in mammary epithelial cells (MEC), thereby protecting the udder against reinfection for some time. Seeking alternatives
to LPS priming we tried to elicit ET by priming MEC with either lipopeptide (Pam2CSK4) via the TLR2/6 axis or
inhibitors of histone-modifying enzymes. Pre-incubation of MEC with Pam2CSK4 enhanced baseline and induced expres-
sion of bactericidal (b-defensin; SLPI) and membrane protecting factors (SAA3, TGM3), while reducing the expression of
cytokine- and chemokine-encoding genes (TNF, IL1) after a subsequent pathogen challenge, the latter, however, not as
efficiently as after LPS priming. Pre-treating MEC with various inhibitors of histone H3 modifiers (for demethylation,
acetylation or deacetylation) all failed to induce any of the protective factors and only resulted in some dampening of
cytokine gene expression after the re-challenge. Hence, triggering immune functions via the TLR axis, but not through
those histone modifiers, induced the beneficial phenomenon of ET in MEC.
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Introduction
Inflammation and infection of the udder (mastitis) is a
frequent and highly relevant disease in dairy farming.1
Infections of Gram-negative pathogens, such as
Escherichia coli, frequently cause severe inflammation
and clinical symptoms.2,3 The risk of suffering from a
new udder infection is by far highest during the first 2
wk after calving,4 hence only during a limited period of
time. It is therefore appealing to search for treatments
that protect the udder against infection during that crit-
ical and timely limited period. Such treatments are best
not based on the application of antibiotics. We have
previously demonstrated the principle feasibility of
such an approach by showing that a short-term (12 h)
local application of a low dose of LPS (1 mg/udder
quarter) into the udder of mid-lactating cows reliably
protected against new infection with E. coli for several
days. The treatment provided a longer lasting (10 d)
protection against severe systemic symptoms in the
case of a successful reinfection.5
We found that LPS priming induced ‘endotoxin tol-
erance’ (ET) in mammary epithelial cells (MEC) was
the likely cause underpinning the reduced infection
probability and milder symptoms during a subsequent
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reinfection.6 MEC are the most abundant cells in the
lactating udder,7 and their pathogen species-specific
immune reaction norm determines the immune
response of the udder early after infection.8
The phenomenon of ET characterizes reduced
immune responsiveness of immune cells to a LPS chal-
lenge subsequent to a previous exposure to E. coli or
LPS.9 ET is induced during sepsis, for example through
excessive LPS-mediated TLR4 stimulation.10 ET has
dual key features. On the one hand, it reduces the
risk of immune pathology during the subsequent LPS
challenge by dampening—or even abrogating—the
induction of pro-inflammatory cytokine- and chemo-
kine-encoding genes. On the other hand, it reduces
the probability of renewed colonization by invading
pathogens through sustaining increased expression of
bactericidal factors.6,11 Key mechanisms underpinning
ET physiology include chromatin remodeling and his-
tone modifications at the promoters of relevant genes.12
Modifications of histone H3 through acetylation and
the addition or removal of methyl groups are of pivotal
importance.13–16 Such modifications, combined with
DNA methylation, will regulate the access of key tran-
scription factors to the promoters.17 Recruitment of
members of the NF-kB factor family is crucial in this
regard,18 as they are key regulators of immune func-
tions.19,20 Recruitment of NF- kBp50 (NFKB1) is par-
ticularly relevant during ET,21,22 not least because this
factor may recruit a repressome onto the target pro-
moters subsequent to excessive TLR4 signaling.23
Excessive stimulation of other TLR receptors, such
as TLR2 or TLR5, may induce ‘cross-tolerance’. This is
an immune refractory state quite similar to ET and may
not only be in elicited in professional immune cells,24–26
but also in alveolar epithelial cells.27
Based on our well-established model of primary
bovine MEC (pbMEC),8,28 we wanted to identify alter-
natives for LPS to protect the udder successfully
against reinfection, as LPS is the prototypical ‘endo-
toxin’ and as such hardly an acceptable pharmaceut-
ical. On the one hand, we explored the value of the
synthetic TLR2/6 ligand, Pam2CSK4,29 as a model
substance for derivatives of bacterial lipopeptides or
lipoproteins to induce ET in MEC. On the other
hand, we examined if pharmaceutically approved
inhibitors of different histone-modifying enzymes
might also be capable of inducing ET in these cells. If
successful, then using such already medically approved
drugs might offer realistic opportunities to develop
applicable novel interventions against mastitis.
Marking histone H3 through the differential addition
of methyl or acetyl groups is accomplished by different
classes of enzymes. Histone acetyltransferases (HATs)
may acetylate H3 to enhance gene expression.13 Hence,
we assumed that blocking histone deacetylases (HDACs)
might result in increased baseline expression of late sec-
ondary response genes encoding bactericidal and
membrane protective factors, while blocking the HATs
should reduce the extent of gene induction after the re-
challenge. This could be particularly desirable for con-
fining the response of the immediate early pro-inflamma-
tory cytokine- and chemokine-encoding genes. We
therefore tested suberoylanilide hydroxamic acid (also
known as SAHA or Vorinostat)13 and trichostatin A
(TSA)30 as small-molecule inhibitors of the HDACs.
S2101 and GSK-J4 served to inhibit lysine-specific his-
tone demethylases 1A or 6B (JMJD3),13,31 and C646 to
block the HAT CREB-binding protein (p300/CBP).32
Parameters for ET induction were the priming and re-
challenge-related modulation of the mRNA concentra-
tion of a selection of master cytokines (TNF-a, IL-1a,
IL-b, IL-6)33–35 and chemokines (CCL2, CCL5, CCL20,
CXCL8, CXCL2);36 and of factors protecting mem-
branes [serum amyloid A3 (SAA3)37 and transglutami-
nase 3 (TGM3)38] and fighting off bacteria (b-defensin
LAP,39 NO synthase NOS2A,40 secreted leukocyte pro-
tease inhibitor SLPI,41 S100A942). We also surveyed the
expression of key transcription factors and transcription
regulators (NF-kBp50; NF- kBIz as an LPS-inducible
regulator,43 acting sometimes as an antagonist to NF-
kBp50/p65 function;44 nuclear receptor subfamily 4
group A member 2, NR4A2—more widely known as
Nurr1—dampening overshooting inflammation45); of
auxiliary factors and regulators of TLR signaling
(CD36,46 CD40,47 SIGIRR48); and of the histone
lysine-specific demethylase 6B (KDM6B), also known
as JMJD3.49
We found that priming with Pam2CSK4 can, indeed,
induce ET in MEC, almost as efficiently as LPS but that
any of the small-molecular inhibitors of histone modi-
fiers would only dampen immune gene expression, but
not significantly enhance expression of any of the pro-
tective factors.
Material and methods
Cell culture procedure, priming and challenge with
heat-inactivated E. coli particles
pbMEC were prepared as described.50 Tissues were
obtained from udders of healthy first lactating cows
slaughtered at our local abattoir, complying with all
pertinent ethical and legal requirements (EU license
ES1635). Cultivation of pbMEC in RPMI 1640
(Biochrom, Berlin, Germany) supplemented with insu-
lin, prolactin, dexamethasone and 10% FCS (PAN-
Biotech, Aidenbach, Germany) was as described in
detail previously.28
Priming and challenge experiments were designed
following our previously published LPS priming pro-
cedure (see scheme in Figure 1).6 Briefly, for priming
experiments (P) the cells were incubated for 12 h
(‘primed’) either with TLR ligands [highly purified
LPS prepared from E. coli strain 1303,6 or
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Pam2CSK4 (InvivoGen, Toulouse, France)] or inhibi-
tors of histone-modifying enzymes [S2101 (Calbiochem,
Merck Millipore, Darmstadt, Germany), C646 (Sigma-
Aldrich, Munich, Germany) or SAHA (Sigma-
Aldrich)]. It was validated that the LPS preparation
used in this study did not activate TLR2
(Supplementary Figure S1). Control cells were culti-
vated for 12 h in normal growth medium (GM). After
12 h, all cells were washed three times with PBS and
subsequently cultivated for an additional 15 h. To
evaluate the effect of priming upon a re-stimulation
[induction post-priming experiments (IpP)] cells were
first primed for 12 h with the respective substance or
cultivated in plain GM as controls, washed three
times with PBS and cultivated for 12 h in GM without
any priming substance added (waiting period).
Subsequently, we supplemented each of these cultures
(primed or un-primed controls) for 3 h with 30 mg/ml
heat-killed E. coli 1303 particles. All cells were har-
vested at 27 h and total RNA was prepared. The
heat-killing procedure for the E. coli pathogens was
just as previously described.51
Vitality assay
Potential cytotoxicity of inhibitors targeting histone-
modifying enzymes (S2101, C646 and SAHA) on
MEC was tested with a MTT assay (Cell Proliferation
Kit I; Roche, Penzberg, Germany). Briefly, cells were
incubated for 12 h in normal growth medium or in
medium containing three different concentration of
the substances (S2101: 5 mM, 50 mM or 500 mM; C646:
2 mM, 20 mM or 200 mM; SAHA: 20 nM, 100 nM or
1000 nM). The number of viable cells were analyzed
with the colorimetric MTT assay as recommended by
the manufacturer. Data are represented relative to the
value from untreated control cultures set as 100%
(Supplementary Figure S2).
RNA extraction and mRNA quantification
Total RNA was extracted with the TRIZOL reagent
(Invitrogen, Thermo Fisher Scientific, Waltham, MA,
USA). Synthesis of cDNA (Superscript II; Invitrogen)
from an input of 75 ng total RNA/sample and quanti-
fication of mRNA by real-time PCR with the Fast-Start
SYBER Green I kit and the LightCycler II instrument
(Roche, Penzberg, Germany) was performed as
described.52 Relative copy numbers were determined
by titration against external standards consisting of
dilution series of plasmids (106–10 copies) harboring
the respective amplicon. Normalization was performed
against the copy numbers of the reference gene chloride
intracellular channel 1 (CLIC1). The expression of this
gene is not regulated in pbMEC in such experimental
settings.53 Sequences of primer pairs are listed in
Supplementary Table S1.
To calculate the priming caused modulation of the
mRNA levels, we set as 1.0 the E. coli stimulation-
caused fold induction as recorded from the un-primed
control cells and expressed the same values as recorded
from the primed cultures as decimals hereof. The inverse
of these values was presented in case they were smaller
than 1.0 (as encountered in the experimental setting of
IpP). If, for example, E. coli induced the expression by
10-fold in the unprimed controls and only by twofold in
the primed cells, then this would be equivalent to only
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Figure 1. Schematic diagram of the experimental setting.
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visualize this difference, we presented the negative value
of the inverse, e.g. 1/0.2¼ –5-fold.
Statistical analysis
Data were analyzed using GraphPad Prism Version 5
(GraphPad Software, Inc., La Jolla, CA, USA). The
Wilcoxon test was applied to evaluate the effect of
Pam2CSK4 priming on the basal (P) and E. coli
induced (IpP) expression of multiple candidate genes.
Repeated-measures ANOVA and Dunnett’s multiple
comparison tests were conducted to estimate the prim-
ing effect of inhibitors targeting histone-modifying
enzymes (S2101, C646, SAHA) on basal (P) and E.
coli-induced (IpP) gene expression.
Results
We evaluated in a first round of experiments if the
TLR2/TLR6 heterodimer ligand Pam2CSK4 would
elicit ET in the pbMEC. We used, in principle, our
previous experimental setting with which we had
proven the efficacy of LPS priming in eliciting ET in
MEC (Figure 1).6 Cells were primed for 12 h with dif-
ferent concentrations of Pam2CSK4. Then the priming
substance was washed away and the cells were either
kept in fresh medium for another 15 h, or challenged
12 h after the wash for another 3 h with 30 mg/ml heat-
killed E. coli 1303 particles. We know from many pre-
vious studies that this stimulus elicits a near-maximal
immune response in MEC.54 LPS-challenged cultures
were eventually run in parallel, serving as positive con-
trols and allowing direct comparison of the efficacy of
the different priming substances.
Effect of priming via the TLR axis upon basal
gene expression
Analysis of the priming effect upon the steady-state
basal level of gene expression is informative as almost
all molecules require constant re-synthesis owing to
their limited half lives. Priming related modulation of
the expression of bactericidal factors is particularly
relevant in this regard as their synthesis and secretion
influences the chemical composition of the alveolar
fluid, the niche in which an intruding pathogen would
have to survive in. We found in the first screenings that
Pam2CSK4 priming modulated in a dose-dependent
fashion the baseline expression of most of our candi-
date pro-inflammatory cytokine and chemokine-
encoding genes, quite similar in magnitude as LPS
priming (Figure 2; Supplementary Table S2). These
genes included TNF, IL1, IL6, CXCL2, CXCL8,
CCL5 and CCL20. Moreover, it also enhanced the
baseline expression of the group of late-responding sec-
ondary immune genes. This group of genes included
those expressing not only the membrane-protecting
factors SAA3 and TGM3, but also the bactericidal fac-
tors b-defensin LAP, SLPI, S100A9 and NOS2A. The
effect of Pam2CSK4 on the expression of those genes
with protective functions was, in tendency, even stron-
ger than that of LPS. For example, Pam2CSK4 priming
increased the mRNA concentration of NOS2A and
SLPI by 5–6-fold as opposed to the 2.5–3-fold increase
caused by LPS.
Neither LPS nor Pam2CSK4 priming substantially
affected the basal mRNA expression of other groups of
genes encoding potentially relevant transcription factors
(NF-kBp50, NF-kBIz, NR4A2), auxiliary factors and
regulators of TLR signaling (CD36, CD40, SIGIRR),
or the JMJD3 factor known to be key for crucial histone
H3-modifications (Supplementary Table S2).
Effect of priming via the TLR axis upon
re-challenge-induced gene expression
Challenging previously primed cells after a 12 h waiting
period in fresh medium with the heat-killed E. coli 1303
particles induced the expression of several of the pro-
inflammatory genes to a lesser extent than recorded
from the un-primed controls (Figure 2;
Supplementary Table S2). However, we noted here a
difference between the LPS- and Pam2CSK4-primed
cells. LPS priming reduced the extent of re-stimula-
tion-dependent induction of gene expression for most
of these genes, in a dose-dependent fashion (TNF, IL-
1, CXCL8, CCL20, CCL2, CCL5, CXCL2), while
Pam2CSK4 priming quenched the extent of their induc-
tion as well, but mostly to a lesser extent and independ-
ent of the concentration of the priming substance. For
example, LPS priming with 1000 ng/ml quenched the
re-challenge-induced mRNA concentration of TNF-a
and IL-1b almost six- and fivefold (TNF-a and IL-1b,
respectively), while priming the cells with Pam2CSK4
lowered these values to only 2–1.7-fold (Supplementary
Table S2). This also applied to the expression NOS2A.
This factor is not only a potent bactericide, but also an
enhancer of inflammation.40 LPS priming dramatically
reduced its re-challenged stimulated expression in a
strongly dose-dependent fashion (<1/10th of the induc-
tion of the un-primed controls, at 1000 ng/ml LPS),
whilst the dampening effect of Pam2CSK4 was
much smaller and independent of the dose of the
primer (–1.3 fold at 1000 ng/ml Pam2CSK4; Figure 2,
Supplementary Table S2).
Pam2CSK4 priming, as well as LPS priming,
enhanced upon re-challenge with E. coli 1303 particles
the expression of the late-responding membrane
protecting and bactericidal factors (Figure 2;
Supplementary Table S2). Indeed, the effect of
Pam2CSK4 priming exceeded in tendency that of LPS
for this group of genes.
Neither of both priming substances modulated the
re-challenge-induced expression of all other groups of
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genes encoding the candidate transcription factors,
auxiliary factors or JMJD3.
Validation that priming with Pam2CSK4 induces
cross-tolerance in MEC
We repeated the priming experiment with the high dose
(1000 ng/ml) of Pam2CSK4 using two more pbMEC
preparations, each derived from a different cow. The
priming effect was statistically significant for the basal
expression of all the early and late immune response
immune genes, supporting the previous observations
(Table 1). Moreover, the re-challenge assays (IpP)
confirmed that this priming regime dampens the patho-
gen-mediated expression of the cytokine- and chemo-
kine-encoding genes together with that of NOS2A,
while it enhances the expression of bactericidal and
membrane-protective factors. Together, the data show
that triggering the immune functions of the MEC via
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Figure 2. Dose dependence of LPS and Pam2CSK4 priming mediated modulated gene expression in pbMEC. (a) Upper diagrams:
fold changes (ordinate) of the relative mRNA concentrations of TNF and TGM3 in response to priming alone for 12 h relative to un-
primed control cultures (cf. Figure 1: ‘Control’). Below: heat map of the expression of other genes, recorded in the same experiment.
The box shows the scale. Numerical values for these and all other analyzed genes are listed in Supplementary Table S2. (b) Same as
above, but values are expressed relative to the extent of E. coli caused induction of the unprimed cultures set as 1.0. Values< 1 are
presented as the negative of the inverse value. Data are mean values ( SEM) from two technical replica experiments of pbMEC
derived from a single cow.
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key aspects of LPS-triggered and TLR4 mediated endo-
toxin tolerance.
Screening for relevant small-molecule inhibitors of
chromatin modifiers
We next examined the efficacy of five different inhibi-
tors of histone-modifying factors for priming immune
functions in MEC. Different concentrations (1–100 mM)
of GSK-J4 inhibiting the H3K27 histone demethylase
JMJD3 had been included into the previous set of
experiments. GSK-J4 priming left the basal expression
of most of the genes virtually unaltered and the extent
of re-challenged-induced gene expression was barely
modulated compared with the un-primed controls
(data not shown). The HDAC inhibitors SAHA and
TSA30 were found in pilot experiments to modulate
quantitatively the expression of responsive genes to a
similar extent. We therefore included into our further
analysis SAHA as the only deacetylase inhibitor and
used C64632 as an inhibitor of the histone acetyl-
transferase and S2101 to inhibit the histone lysine
demethylase.13 We validated that our pbMEC could tol-
erate the published physiologically relevant concentra-
tions for SAHA (1–100nM)55 for C646 (10–50mM)32,56
and for S2101 (1–50mM).57 It was reported that C646
would be inhibited by the addition of FCS to the
medium,56 while others proved its physiological activity
in mM concentrations in medium containing 10% FCS.58
We found that its application in serum-free medium
stressed our pbMEC resulting in cell death, as indicated
by poor cell growth and 10-fold reduced RNA yield per
culture dish at high concentrations (50mM). Moreover,
omission of serum significantly alters the immune
response of pbMEC.53 Hence, we decided to apply
C646 in medium containing 10% FCS.
Inhibitors of chromatin modifiers are dampeners
rather than enhancers of immune gene
expression in MEC
Based on the experiences gathered in those pilot experi-
ments, we monitored the efficacy of priming immune
functions in pbMEC in two biological replica experi-
ments each assayed in duplicate using pbMEC cultures
derived from different cows. None of these inhibitors
significantly increased the basal expression of most of
our candidate genes (Table 2). Blocking the demethy-
lases through S2101 and HATs through C646 affected
the basal mRNA concentration in tendency quite simi-
larly resulting either in no change (IL-1b) or some
down-regulation. Only the high concentration of
C646 (20mM) raised the level on the CXCL8 mRNA
by 1.9-fold. Blocking the HDACs through SAHA
resulted in even fewer changes of the basal mRNA con-
centrations. As exceptions, we found for SAHA that
priming with the high concentration (100 nM) increased
the level of SLPI mRNA by 1.8-fold. This SAHA con-
centration also increased the SAA3 mRNA concentra-
tion by fourfold. Yet, priming with Pam2CSK4 had
consistently increased this level by far more than> 100
fold (Table 1). We found, as a rule, that the extent by
which the three different classes of inhibitors modulated
the basal mRNA levels was smaller by almost an order
of magnitude than encountered after priming the cells
with either of both TLR ligands.
Re-challenging the primed cells with the strong E.
coli stimulus did not increase the expression of any of
the genes but eventually caused only a down-regula-
tion. Significantly, we found down- rather than up-reg-
ulation for the expression of almost all of the late
secondary immune genes, including all those encoding
protective and bactericidal factors (Table 2).
Discussion
The goal of our ongoing work is to identify substances
other than LPS that are capable of calibrating, after a
local application, udder responsiveness to a repeated
bacterial infection in a beneficial direction. The treat-
ment should harness the bactericidal capacity of MEC
and at the same time dampen their inflammation-elicit-
ing potential. As a first step we tested here the efficacy
of a variety of candidate substances for priming the
immune responsiveness of pbMEC cultures and re-
challenging them after a 12-h waiting period. We have
previously validated this experimental setting by glo-
bally profiling the transcriptome of LPS-primed
pbMEC,6 and also exemplified for IL-1A,51 and the
mRNA stability regulating factor tristetraprolin,54
that increased mRNA concentrations eventually





TNF 10.2 3.0c –1.3 0.1
IL1B 6.9 1.8 –1.6 0.1
IL6 25.2 7.3 1.7 0.4
CXCL8 6.0 0.7 –1.2 0.1
NOS2A 3.5 0.5 –1.7 0.2
TGM3 3.2 0.7 3.9 0.7
SLPI 10.8 1.8 6.1 1.4
SAA3 204.6 106.7 3.7 1.1
LAP 4.3 0.2 2.7 0.3
aPriming was with 1000 ng/ml of Pam2CSK4 for 12 h. bE. coli induction
post-priming was for 3 h (see Figure 1), both treatments were applied in
the same experimental setting as explained in Figure 2. Gray underlay,
significant change (P< 0.05, Wilcox signed rank test). cValues are fold
changes of mRNA concentrations relative to unprimed control cultures
(means SEM from three different biological replica cultures, each
assayed in duplicate).
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correlate with increased protein concentrations in these
model cells. In the present study, we recorded as a read-
out the priming effect upon the re-challenge-caused
induction of gene expression only at a single time
point, at 3 h after the re-challenge. This is a comprom-
ise, considering the differential expression kinetics of
primary and secondary immune-response genes. The
mRNA concentrations of fast-responding primary
immune genes (some cytokine- and chemokine-encod-
ing genes)59 will peak within a few hours after a chal-
lenge,54 while those of some secondary response genes
(e.g. LAP, SAA3) will steadily increase after the chal-
lenge, after an initial lag period of approximately
1 h.54,60 We know from many experiments that 3 h
after the challenge the mRNA concentrations of the
fast-reacting genes will still be elevated, while those of
the slow-responding secondary genes only have started
to rise.53,54,60 Therefore, the magnitude of the priming
effect upon inducing the expression of the b-defensin
LAP, for example, may have been considerably under-
estimated. Of note, we consider LAP expression only as
an indicator and a paradigm for the more than 100
individual b-defensin-encoding genes of the bovine
genome.61
Our first key observation is that priming immune
functions in MEC via the TLR2/6 axis is possible and
potentially as feasible as using LPS priming. Hence,
induction of cross-tolerance through lipopeptides or
other TLR2 ligands is possible in this cell type.
This finding is novel for MEC and offers the possibility
to eliciting ET in MEC with pure chemically synthe-
sized molecules being much better defined than even
the most highly purified LPS preparation derived
from bacteria. It emerged, as second main result that
inhibiting single enzymes involved in modifying histone
H3 does not induce the complex features of endotoxin
tolerance.
Induction of cross-tolerance in MEC through TLR2
ligands may protect the udder from reinfection
Pam2CSK4 priming elicited in MEC both dual key fea-
tures of endotoxin tolerance. It dampened the re-stimu-
lation-induced expression of the master regulators of
inflammation, TNF and IL1B, and increased the basal
expression of factors protecting the udder cells against
damage (SAA3, TGM3) and some of those with bac-
tericidal function (SLPI, LAP, NOS2A). Increasing the
basal level of protective factors in epithelial cells is a
major beneficial aspect of endotoxin tolerance as this
will reduce the probability of reinfection by enforcing
the bactericidal properties of the alveolar fluid.
Enhanced expression of protective factors during ET
is well known,11 but has not often been considered in
the many studies analyzing endotoxin tolerance in pro-
fessional immune cells. Pam2CSK4 priming enhanced
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expression the membrane protective factors, to the
same or even slightly stronger extent than encountered
with LPS. Hence, priming immune functions through
the TLR2/6 axis might yield as good an immune pro-
tection of the udder against re-colonization as priming
with LPS via the TLR4 axis, albeit that the TLR2 sig-
naling cascade is less complex than that of TLR4.62
Our data may serve as a platform to validating the
physiological relevance of such treatments in a relevant
animal model.5 Moreover, only such in vivo experi-
ments can show if serious problems arise through the
reduced capacity of the TLR2 axis mediated priming to
confining the potentially harmful induction of the
master cytokines (TNF-a, IL-1b) and of NOS2A
during re-challenges.
Blocking histone modifications modified the immune
reactivity into an undesired direction
Priming the cells should, upon re-stimulation, dampen
the exuberant expression of inflammatory cytokines
and, at the same time, result in sustained increased
expression bactericidal and membrane protective fac-
tors. However, the treatments with inhibitors of his-
tone-modifying enzymes only partly fulfilled these
expectations. Our inhibitors of histone modulators sub-
stantially quenched the expression of only some of our
candidate cytokine- and chemokine-encoding genes
(TNF, CCL5) but not of IL1B or CXCL8. This may
be owing to the fact that the chromatin at promoters of
resting primary immune response genes is known to be
in an ‘open’ configuration, with necessary transcription
factors having already been recruited so that these
genes are poised to react immediately upon an
incoming stimulus.63,64 Hence, there may be no need
for extensive chromatin remodeling to trigger their
expression.
However, the general failure of the three classes of
inhibitors to increase substantially the basal expression
of the protective factors was unexpected and clearly
disqualifies them as suitable candidate substances.
The demethylase inhibitor S2101 very significantly
quenched the basal, as well as the re-challenge-induced
expression of all the respective candidate genes. This
suggests that their expression may, in part, be confined
through repressive histone methylation, such as
H3K27me3. Moreover, the particularly strong repres-
sive effect of C646 upon re-stimulating their expression
could indicate that de novo acetylation of histone H3,
for instance at H3K14, might be of key importance for
activating their expression. However, we can only
speculate about the mechanisms underpinning the
effect of these treatments, as our study was not designed
to dissect any of the myriad of mechanisms being trig-
gered through differential histone modifications. Such
an analysis into the mechanisms would also need to
consider potential off-target and side effects of those
inhibitors. C646, for example, not only blocks H3
acetylation, but also the function of the p300/CBP tran-
scriptional co-activator. p300 itself is a promiscuous
acetyl transferase with more than 75 targets, including
NF-kB factors (see Bowers et al.32 for a review).
Our study shows that only priming the immune
responsiveness of MEC through the TLR axis induced
the dual features of endotoxin tolerance, dampening
overshooting inflammation and at the same time har-
nessing the bactericidal and cell-protective functions.
ET is an ancient memory of the innate immune
system that exists already in teleostean fish.65
Obviously, priming immune competence and reactivity
through TLR ligands triggers a very complex response
network having been evolutionarily streamlined
for> 450 million yr, before the radiation of the teleos-
tean fish from all other vertebrates.66 It is activated by
even older bacterial molecular patterns derived from
structural core components of pathogens having func-
tionally been optimized for> 2 billion yr. All TLR sig-
naling converges ultimately in NF- kB activation. A
pivotally important TLR-signaling-triggered NF- kB
activation for the induction of ET has previously
been reported.23 However, priming the immune respon-
siveness of these cells by selectively interfering with a
single class of epigenetic regulators will only modulate a
sub-section of the mechanisms operating during ET
rather than adequately activate the entirety of this regu-
latory network.
In summary, our study validates that mimetics for
bacterial lipopeptides and lipoproteins are capable of
inducing the beneficial features of ET in mammary epi-
thelial cells. Their derivatives might therefore serve
as promising candidate substances in eliciting a timely
limited immune protection in the udder. Our data may
serve as a platform for validating the physiological rele-
vance in vivo. However, we also show that our selected
modulators of epigenetic regulators all failed to harness
the cell protective and bactericidal features of ET
in MEC.
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